| KIF5B-RET fusions in lung adenocarcinoma T Kohno, H Ichikawa, Y Totoki, K Yasuda, M Hiramoto, T Nammo, ... Nature medicine 18 (3), 375-377, 2012 | 998 | 2012 |
| Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. D Ryberg, V Skaug, A Hewer, DH Phillips, LW Harries, CR Wolf, D Ogreid, ... Carcinogenesis 18 (7), 1285-1289, 1997 | 573 | 1997 |
| Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes JD McKay, RJ Hung, Y Han, X Zong, R Carreras-Torres, DC Christiani, ... Nature genetics 49 (7), 1126-1132, 2017 | 559 | 2017 |
| Polymorphisms of DNA repair genes and risk of non-small cell lung cancer S Zienolddiny, D Campa, H Lind, D Ryberg, V Skaug, L Stangeland, ... Carcinogenesis 27 (3), 560-567, 2006 | 546 | 2006 |
| Association of a common polymorphism in the cyclooxygenase 2 gene with risk of non-small cell lung cancer D Campa, S Zienolddiny, V Maggini, V Skaug, A Haugen, F Canzian Carcinogenesis 25 (2), 229-235, 2004 | 275 | 2004 |
| Human CYP1A1 (cytochrome P1450) gene: lack of association between the Msp I restriction fragment length polymorphism and incidence of lung cancer in a Norwegian population T Tefre, D Ryberg, A Haugen, DW Nebert, V Skaug, A Brøgger, ... Pharmacogenetics and Genomics 1 (1), 20-25, 1991 | 253 | 1991 |
| The association of microRNA expression with prognosis and progression in early-stage, non–small cell lung adenocarcinoma: a retrospective analysis of three cohorts M Saito, AJ Schetter, S Mollerup, T Kohno, V Skaug, ED Bowman, ... Clinical cancer research 17 (7), 1875-1882, 2011 | 238 | 2011 |
| p53mutations in lung tumours: relationship to gender and lung DNA adduct levels EH Kure, D Ryberg, A Hewer, DH Phillips, V Skaug, R Bæera, A Haugen Carcinogenesis 17 (10), 2201-2205, 1996 | 225 | 1996 |
| Association of a functional polymorphism in the promoter of the MDM2 gene with risk of nonsmall cell lung cancer H Lind, S Zienolddiny, PO Ekstrøm, V Skaug, A Haugen International journal of cancer 119 (3), 718-721, 2006 | 184 | 2006 |
| Polymorphisms of the interleukin‐1 β gene are associated with increased risk of non‐small cell lung cancer S Zienolddiny, D Ryberg, V Maggini, V Skaug, F Canzian, A Haugen International journal of cancer 109 (3), 353-356, 2004 | 178 | 2004 |
| Sex differences in risk of lung cancer: expression of genes in the PAH bioactivation pathway in relation to smoking and bulky DNA adducts S Mollerup, G Berge, R Bæra, V Skaug, A Hewer, DH Phillips, ... International journal of cancer 119 (4), 741-744, 2006 | 174 | 2006 |
| A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of non-small cell lung cancer in smokers S Zienolddiny, D Campa, H Lind, D Ryberg, V Skaug, LB Stangeland, ... Carcinogenesis 29 (6), 1164-1169, 2008 | 162 | 2008 |
| Genome-wide analysis of survival in early-stage non–small-cell lung cancer YT Huang, RS Heist, LR Chirieac, X Lin, V Skaug, S Zienolddiny, ... Journal of clinical oncology 27 (16), 2660-2667, 2009 | 156 | 2009 |
| Multi-walled carbon nanotube physicochemical properties predict pulmonary inflammation and genotoxicity SS Poulsen, P Jackson, K Kling, KB Knudsen, V Skaug, ZO Kyjovska, ... Nanotoxicology 10 (9), 1263-1275, 2016 | 152 | 2016 |
| p53 Mutations in Lung Tumors: Relationship to Putative Susceptibility Markers for Cancer D Ryberg, E Kure, S Lystad, V Skaug, L Stangeland, I Mercy, AL Børresen, ... Cancer research 54 (6), 1551-1555, 1994 | 145 | 1994 |
| p53 Mutations in Defined Structural and Functional Domains Are Related to Poor Clinical Outcome in Non-Small Cell Lung Cancer Patients V Skaug, D Ryberg, EHKMO Arab, L Stangeland, AO Myking, A Haugen Clinical Cancer Research 6 (3), 1031-1037, 2000 | 118 | 2000 |
| A specific interleukin-1B haplotype correlates with high levels of IL1B mRNA in the lung and increased risk of non-small cell lung cancer NE Landvik, K Hart, V Skaug, LB Stangeland, A Haugen, S Zienolddiny Carcinogenesis 30 (7), 1186-1192, 2009 | 114 | 2009 |
| An integrated prognostic classifier for stage I lung adenocarcinoma based on mRNA, microRNA, and DNA methylation biomarkers AI Robles, E Arai, EA Mathé, H Okayama, AJ Schetter, D Brown, ... Journal of Thoracic Oncology 10 (7), 1037-1048, 2015 | 112 | 2015 |
| The TERT-CLPTM1L lung cancer susceptibility variant associates with higher DNA adduct formation in the lung S Zienolddiny, V Skaug, NE Landvik, D Ryberg, DH Phillips, R Houlston, ... Carcinogenesis 30 (8), 1368-1371, 2009 | 111 | 2009 |
| DNA methylation at promoter regions of interleukin 1B, interleukin 6, and interleukin 8 in non-small cell lung cancer X Tekpli, NE Landvik, KH Anmarkud, V Skaug, A Haugen, S Zienolddiny Cancer Immunology, Immunotherapy 62, 337-345, 2013 | 98 | 2013 |
